Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study

Pertussis is a highly contagious disease, for which periodic peaks in incidence and an increasing number of outbreaks have been observed over the last decades. The reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine (Tdap) can be used to boost individuals aged ≥10 years, vaccinate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovac, Martina, Kostanyan, Lusiné, Mesaros, Narcisa, Kuriyakose, Sherine, Varman, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149833/
https://www.ncbi.nlm.nih.gov/pubmed/29630439
http://dx.doi.org/10.1080/21645515.2018.1460292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149833/
https://www.ncbi.nlm.nih.gov/pubmed/29630439
http://dx.doi.org/10.1080/21645515.2018.1460292

Ejemplares similares